Hutchison China MediTech Ltd. | Mutual Funds
Mutual Funds that own Hutchison China MediTech Ltd.
MFM Slater Growth Fund
1,130,708
1.7%
0
10.96%
04/28/2017
Fidelity China Special Situations Plc (Top 40 Holdings)
1,074,078
1.61%
-32,569
2.9%
03/31/2018
Fidelity Funds SICAV - Pacific Fund
520,601
0.78%
-34,656
1.26%
05/31/2018
Marlborough Special Situations Fund
485,000
0.73%
-11,401
1.35%
03/29/2018
M&G International Specialist Equity Fund
252,050
0.38%
0
3.38%
03/29/2018
Harvest Overseas Chinese Equity Fund
141,587
0.21%
141,587
0.92%
12/31/2017
Artemis Strategic Assets Fund
130,000
0.2%
-20,000
0.68%
06/29/2018
MFM Slater Recovery Fund
129,218
0.19%
-5,282
15.28%
03/31/2017
T Rowe Price Funds SICAV - European Smaller Companies Equity
88,299
0.13%
14,835
1.62%
06/30/2018
Standard Life Investment Co. ICVC - UK Equity High Alpha Fund
67,790
0.1%
6,201
1.26%
08/31/2018
| Address |
Cheung Kong Center
Hong Kong
Hong Kong
|
|
Employees
|
- |
| Website |
http://www.chi-med.com |
| Updated |
07/08/2019 |
| Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases. |
